基于知信行理论的认知行为干预模式在多发性骨髓瘤患者中的应用分析

Application of cognitive behavioral intervention model based on knowledge attitude practice theory in patients with multiple myeloma

目的:探讨在知信行理论指导下的认知行为干预在多发性骨髓瘤患者的应用效果。方法:将2019年1月~2020年6月在南京医科大学附属无锡市人民医院住院治疗的96例多发性骨髓瘤患者作为研究对象,按照随机数字分组原则分为对照组和观察组各48例,对照组采用常规护理,观察组采用知信行理论指导下的认知行为干预模式,比较干预前、干预后3个月两组患者的生命质量测定量表、自我照护能力评分及焦虑、抑郁自评量表、疼痛评分。结果:干预前,两组患者的生命质量测定量表、自我照护能力评分及焦虑、抑郁自评量表、疼痛评分差异无统计学意义(P>0.05);干预后3个月,观察组患者生命质量测定量表评分及自我照护能力评分大于对照组患者,焦虑、抑郁自评量表评分、疼痛评分小于对照组患者,差异有统计学意义(P<0.05)。结论:多发性骨髓瘤患者采用知信行理论指导下的认知行为干预可以有效提高患者生命质量和自我照护能力,降低患者焦虑、抑郁不良情绪,从而有效缓解患者的疼痛感,效果明显,值得临床推广。

Objective To explore the application effect of cognitive behavior intervention under the guidance of KAP theory in patients with multiple myeloma.Method 96 patients with multiple myeloma in our hospital from January 2019 to June 2020 were randomly divided into control group and observation group,48 cases in each group.The control group was given routine nursing,while the observation group was given cognitive behavior intervention mode under the guidance of KAP theory.The quality of life of cancer patients in the two groups before and after the intervention was compared Quantitative scale,self-care ability score,self rating anxiety and depression scale,pain score.Results Before the intervention,there was no significant difference in the quality of life scale,self-care ability score,self rating anxiety and depression scale and pain score between the two groups(P>0.05).Three months after the intervention,the scores of quality of life and self-care ability in the observation group were higher than those in the control group,while the scores of anxiety,depression and pain in the observation group were lower than those in the control group(P<0.05).Conclusion Cognitive behavior intervention under the guidance of KAP theory can effectively improve the quality of life and self-care ability of patients with multiple myeloma,reduce the anxiety and depression of patients,so as to effectively relieve the pain of patients,with obvious effect,which is worthy of clinical promotion.